A Nano-Integrated Diagnostic and Therapeutic Platform with Oxidation-Reduction Reactions in Tumor Microenvironments.

Lei Zhao,Guihua Qiu,Kai Wang,Hu Chen,Fengkai Ruan,Nan Liu,Zifeng Deng,Youliang Yao,Dongbei Guo,Dai Wang,Li Sha,Xiangyu Kong,Wenzhi Liu,Yongxing Zhang
DOI: https://doi.org/10.1039/c9na00786e
IF: 5.598
2020-01-01
Nanoscale Advances
Abstract:In the present study, we developed a nano-integrated diagnostic and therapeutic platform with oxidation-reduction reactions in tumor microenvironments (TMEs). The proposed platform resolved the contradiction of particle size between the enhanced permeability and retention (EPR) effect and tumor interstitial penetration, as well as poor circulation and low drug-loading efficiency. Flower-like MnO2 NPs were used as the core and modified with hyaluronate (HA) and H2PtCl6 to obtain MnO2-HA@H2PtCl6 (MHP). The maximum drug-loading efficiency rate of H2PtCl6 reached 35% due to its chelation with HA. MHP showed satisfactory integrity and stability during circulation and can also be used as a magnetic resonance imaging (MRI) contrast agent. In addition, MHP as a radiosensitizer achieved an excellent tumor inhibition effect in combination with radiotherapy. Importantly, MHP released ultra-small nanoparticles, USNPs, (∼20 nm) through the supramolecular self-assembly abilities of Mn2+, HA, and H2PtCl6 in TMEs, leading to the increase of penetration into multicellular spheres and solid tumors (Scheme), as well as prolonging its retention in tumors.
What problem does this paper attempt to address?